A 64-year-old with ischemic cardiomyopathy (EF 30%) on ACEi/β‑blocker only. According to HF guideline, which core drug class should be added to comple...

Question

A 64-year-old with ischemic cardiomyopathy (EF 30%) on ACEi/β‑blocker only. According to HF guideline, which core drug class should be added to complete foundational quadruple therapy?

Accepted Answer

MRA, ARNI, and SGLT2 inhibitor

Answer

Loop diuretic

Answer

Hydralazine only

Answer

Ivabradine only

Answer

Digoxin

us-abim MCQ (SBA): HFrEF (quadruple therapy)

A 64-year-old with ischemic cardiomyopathy (EF 30%) on ACEi/β‑blocker only. According to HF guideline, which core drug class should be added to complete foundational quadruple therapy?